Dengue in the context of "safe blood" and global epidemiology: to screen or not to screen?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Prevalence of Zika virus in blood donations: a systematic review and meta-analysis.BMC infectious diseases · 2019
   Pooled it
2. Serodetection of Dengue virus and its antibodies among blood donors in the western region of Saudi Arabia: a preliminary study.Blood transfusion = Trasfusione del sangue · 2015
   Trial
3. Strengthening resilience to emerging vector-borne diseases in Europe: lessons learnt from countries facing endemic transmission.The Lancet regional health. Europe · 2025
   Review
4. Neurological Manifestations of Perinatal Dengue.Newborn (Clarksville, Md.) · 2023
   Article
5. Mitigating the risk of transfusion-transmitted infections with vector-borne agents solely by means of pathogen reduction.Transfusion · 2022
   Article
6. Assessment of dengue virus threat to blood safety and community health: A single center study in northern Egypt.Journal of virus eradication · 2022
   Article
7. Detection of dengue, chikungunya, and Zika RNA in blood donors from Southeast Asia.Transfusion · 2021
   Article
8. Dengue Virus Infection of Blood-Brain Barrier Cells: Consequences of Severe Disease.Frontiers in microbiology · 2019
   Review
9. Seroprevalence of Asymptomatic Dengue Virus Infection and Its Antibodies Among Healthy/Eligible Saudi Blood Donors: Findings From Holy Makkah City.Virology : research and treatment · 2017
   Article
10. Mitigating the Risk of Transfusion-Transmitted Dengue in Australia.Journal of blood transfusion · 2016
    Article
11. Transplantation in the tropics: lessons on prevention and management of tropical infectious diseases.Current infectious disease reports · 2015
    Article
12. Evaluation of inapparent dengue infections during an outbreak in Southern China.PLoS neglected tropical diseases · 2015
    Article
13. Preparation, quality criteria, and properties of human blood platelet lysate supplements for ex vivo stem cell expansion.New biotechnology · 2015
    Review
14. Current perspectives in transfusion-transmitted infectious diseases: emerging and re-emerging infections.ISBT science series · 2014
    Article
15. Current epidemiology and clinical practice in arboviral infections - implications on blood supply in South-East Asia.ISBT science series · 2014
    Article
16. Pathogen inactivation technologies for cellular blood components: an update.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2014
    Review
17. The National Heart, Lung, and Blood Institute Recipient Epidemiology and Donor Evaluation Study (REDS-III): a research program striving to improve blood donor and transfusion recipient outcomes.Transfusion · 2014
    Article
18. Implications of dengue outbreaks for blood supply, Australia.Emerging infectious diseases · 2013
    Article
19. Prevalence of dengue NS1 antigenemia among healthy blood donors in a tertiary care hospital in Southern India.Asian journal of transfusion science
    Article
20. Transmission of dengue virus from deceased donors to solid organ transplant recipients: case report and literature review.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as